EcoDrugPlus

Histone Deacetylase 2

Ensembl ID : ENSOPRG00000003019
Gene Symbol: HDAC2
1 Cross references
203 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSOPRG00000016937
Gene Symbol: HDAC3
3 Cross references
156 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSOPRG00000008571
Gene Symbol: HDAC5
1 Cross references
194 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSOPRG00000010179
Gene Symbol: HDAC7
1 Cross references
260 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSOPRG00000002816
Gene Symbol: HDAC8
1 Cross references
201 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSOPRG00000017251
Gene Symbol: HDAC9
1 Cross references
234 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 2

Ensembl ID : ENSOPRG00000013905
Gene Symbol: LOC101535493
2 Cross references
165 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSOPRG00000014249
Gene Symbol: HSD11B1
1 Cross references
248 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSOPRG00000013307
Gene Symbol: HCRTR1
1 Cross references
96 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSOPRG00000005529
Gene Symbol: IDO1
1 Cross references
98 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSOPRG00000012153
Gene Symbol: IKBKB
1 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSOPRG00000015168
Gene Symbol: IMPDH1
1 Cross references
333 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).